Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 68

1.

A Novel Factor I Activity in Nipah Virus Inhibits Human Complement Pathways through Cleavage of C3b.

Johnson JB, Borisevich V, Rockx B, Parks GD.

J Virol. 2015 Jan 15;89(2):989-98. doi: 10.1128/JVI.02427-14. Epub 2014 Oct 29.

PMID:
25355897
[PubMed - in process]
2.

Mission critical: mobilization of essential animal models for ebola, nipah, and machupo virus infections.

Zumbrun EE.

Vet Pathol. 2015 Jan;52(1):18-20. doi: 10.1177/0300985814556781. Epub 2014 Oct 28.

PMID:
25352204
[PubMed - in process]
3.

Rhabdovirus-Based Vaccine Platforms against Henipaviruses.

Kurup D, Wirblich C, Feldmann H, Marzi A, Schnell MJ.

J Virol. 2015 Jan 1;89(1):144-54. doi: 10.1128/JVI.02308-14. Epub 2014 Oct 15.

PMID:
25320306
[PubMed - in process]
4.

From risk analysis to risk governance - Adapting to an ever more complex future.

Pfeiffer DU.

Vet Ital. 2014 Jul-Sep;50(3):169-76. doi: 10.12834/VetIt.313.1220.3.

PMID:
25273958
[PubMed - in process]
Free Article
5.

Methyltransferase-defective avian metapneumovirus vaccines provide complete protection against challenge with the homologous Colorado strain and the heterologous Minnesota strain.

Sun J, Wei Y, Rauf A, Zhang Y, Ma Y, Zhang X, Shilo K, Yu Q, Saif YM, Lu X, Yu L, Li J.

J Virol. 2014 Nov;88(21):12348-63. doi: 10.1128/JVI.01095-14. Epub 2014 Aug 13.

PMID:
25122790
[PubMed - in process]
6.

Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibody.

Geisbert TW, Mire CE, Geisbert JB, Chan YP, Agans KN, Feldmann F, Fenton KA, Zhu Z, Dimitrov DS, Scott DP, Bossart KN, Feldmann H, Broder CC.

Sci Transl Med. 2014 Jun 25;6(242):242ra82. doi: 10.1126/scitranslmed.3008929.

PMID:
24964990
[PubMed - in process]
7.

Evaluation of luciferase and GFP-expressing Nipah viruses for rapid quantitative antiviral screening.

Lo MK, Nichol ST, Spiropoulou CF.

Antiviral Res. 2014 Jun;106:53-60. doi: 10.1016/j.antiviral.2014.03.011. Epub 2014 Mar 27.

PMID:
24680955
[PubMed - indexed for MEDLINE]
8.

Single-dose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies directed against surface glycoproteins.

DeBuysscher BL, Scott D, Marzi A, Prescott J, Feldmann H.

Vaccine. 2014 May 7;32(22):2637-44. doi: 10.1016/j.vaccine.2014.02.087. Epub 2014 Mar 12.

PMID:
24631094
[PubMed - indexed for MEDLINE]
9.

Emerging viral diseases of livestock in the developing world.

Bayry J.

Indian J Virol. 2013 Dec;24(3):291-4. doi: 10.1007/s13337-013-0164-x. Epub 2013 Nov 10.

PMID:
24426290
[PubMed]
Free PMC Article
10.

Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease.

Mire CE, Versteeg KM, Cross RW, Agans KN, Fenton KA, Whitt MA, Geisbert TW.

Virol J. 2013 Dec 13;10:353. doi: 10.1186/1743-422X-10-353.

PMID:
24330654
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Single-dose replication-defective VSV-based Nipah virus vaccines provide protection from lethal challenge in Syrian hamsters.

Lo MK, Bird BH, Chattopadhyay A, Drew CP, Martin BE, Coleman JD, Rose JK, Nichol ST, Spiropoulou CF.

Antiviral Res. 2014 Jan;101:26-9. doi: 10.1016/j.antiviral.2013.10.012. Epub 2013 Oct 30.

PMID:
24184127
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Crystal structure of the Hendra virus attachment G glycoprotein bound to a potent cross-reactive neutralizing human monoclonal antibody.

Xu K, Rockx B, Xie Y, DeBuysscher BL, Fusco DL, Zhu Z, Chan YP, Xu Y, Luu T, Cer RZ, Feldmann H, Mokashi V, Dimitrov DS, Bishop-Lilly KA, Broder CC, Nikolov DB.

PLoS Pathog. 2013;9(10):e1003684. doi: 10.1371/journal.ppat.1003684. Epub 2013 Oct 10.

PMID:
24130486
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Hendra and Nipah infection: emerging paramyxoviruses.

Aljofan M.

Virus Res. 2013 Nov 6;177(2):119-26. doi: 10.1016/j.virusres.2013.08.002. Epub 2013 Aug 13.

PMID:
23954578
[PubMed - indexed for MEDLINE]
14.

Vaccination of ferrets with a recombinant G glycoprotein subunit vaccine provides protection against Nipah virus disease for over 12 months.

Pallister JA, Klein R, Arkinstall R, Haining J, Long F, White JR, Payne J, Feng YR, Wang LF, Broder CC, Middleton D.

Virol J. 2013 Jul 16;10:237. doi: 10.1186/1743-422X-10-237.

PMID:
23867060
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

A treatment for and vaccine against the deadly Hendra and Nipah viruses.

Broder CC, Xu K, Nikolov DB, Zhu Z, Dimitrov DS, Middleton D, Pallister J, Geisbert TW, Bossart KN, Wang LF.

Antiviral Res. 2013 Oct;100(1):8-13. doi: 10.1016/j.antiviral.2013.06.012. Epub 2013 Jul 6. Review.

PMID:
23838047
[PubMed - indexed for MEDLINE]
Free Article
16.

Passive immunization and active vaccination against Hendra and Nipah viruses.

Broder CC.

Dev Biol (Basel). 2013;135:125-38. doi: 10.1159/000171017. Epub 2013 May 14.

PMID:
23689890
[PubMed - indexed for MEDLINE]
17.

Emerging viral infections.

Wilson MR.

Curr Opin Neurol. 2013 Jun;26(3):301-6. doi: 10.1097/WCO.0b013e328360dd2b. Review.

PMID:
23591683
[PubMed - indexed for MEDLINE]
18.

Recombinant measles virus vaccine expressing the Nipah virus glycoprotein protects against lethal Nipah virus challenge.

Yoneda M, Georges-Courbot MC, Ikeda F, Ishii M, Nagata N, Jacquot F, Raoul H, Sato H, Kai C.

PLoS One. 2013;8(3):e58414. doi: 10.1371/journal.pone.0058414. Epub 2013 Mar 14.

PMID:
23516477
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Medical aspects of bio-terrorism.

Balali-Mood M, Moshiri M, Etemad L.

Toxicon. 2013 Jul;69:131-42. doi: 10.1016/j.toxicon.2013.01.005. Epub 2013 Jan 20.

PMID:
23339855
[PubMed - indexed for MEDLINE]
20.

Henipavirus pathogenesis in human respiratory epithelial cells.

Escaffre O, Borisevich V, Carmical JR, Prusak D, Prescott J, Feldmann H, Rockx B.

J Virol. 2013 Mar;87(6):3284-94. doi: 10.1128/JVI.02576-12. Epub 2013 Jan 9.

PMID:
23302882
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk